Maternal and Fetal Platelet Responses and Adrenoceptor Binding Characteristics

Summary

Paired blood samples were obtained from mothers (venous) and babies (cord venous blood) at the time of delivery by caesarean section under epidural anaesthetic. Fetal platelets failed to aggregate in response to adrenaline in vitro although adrenaline could potentiate the threshold response to adenosine diphosphate (1 μM). Fetal platelet responses to collagen and 8 Arg vasopressin did not differ significantly from maternal responses. Maternal and fetal platelets also showed similar inhibition of aggregation after activation of adenylate cyclase (PGE₁ and parathormone), in contrast to the inhibition of adenylate cyclase by adrenaline.

Alpha₂ adrenoceptors were investigated using [³H] yohimbine binding receptor number and were reduced modestly but significantly on fetal compared to maternal platelets. The failure of fetal platelet aggregation in response to adrenaline appears to be related to a failure of receptor coupling and may represent a delayed maturation of fetal platelet alpha receptors or a response- to increased circulating catecholamines during birth.

Key words

Platelet - Adrenoceptor - Fetal - Maternal

• References

• 1 Cotton ML, Berkowitz BA. Vascular Contraction: Effect of age and extracellular calcium. Blood Vessels 1976; 13: 139-154
• 2 Cotton ML, Berkowitz BA. Difference between the effects of dopamine and apomorphine on rat aortic strips. Eur J Pharmacol 1975; 35: 49-58
• 3 Hall JE, Mokler CM. Loss of H₂ histamine receptor activity in rabbit aorta after maturity. J Cardiovasc Pharmacol 1982; 4: 136-141
• 4 Chen F-CM, Yamamura JI, Rouske WR. Ontogeny of mammalian myocardial a adrenergic receptors. Eur J Pharmacol 1979; 58: 255-264
• 5 Grant JA, Scrutton MC. Interaction of selective a-adrenoceptor agonists and antagonists with human and rabbit blood platelets. Br J Pharmacol 1980; 71: 121-134
• 6 Daiguji M, Meltzer HY, U’Prichard DC. Human platelet α₂adrenergic receptors: labelling with³H yohimbine, a selective antagonist ligand. Life Sci 1981; 28: 2705-2717
• 7 Alexander WA, Cooper B, Handin RI. Characterisation of the human platelet adrenergic receptor. J Clin Invest 1978; 61: 1136-1144
• 8 Corby DG, Barr TP. Decreased alpha adrenergic receptors in newborn. Cause of abnormal response to epinephrine Paediatr Pharmacol Ther 1971; 79: 307-313
• 9 Mull MM, Hathaway WE. Altered platelet function in the newborn. Paedtr Res 1970; 4: 229-237
• 10 Born GV R. Quantitative investigations into the aggregation of blood platelets. J Physiol (Lond) 1962; 162: 167
• 11 Scatchard G. The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 1949; 660-672
• 12 Remuzzi G, Dodesini P, Livio M, Mecca G, Benigni A, Schieppati A, Poletti E, Gaetano G. Parathyroid Hormone inhibits human platelet function. Lancet 1981; 2: 1321-1323
• 13 Barradas MA, Craft IL, Danduna P. Does the human placenta produce prostaglandin?. J Physiol 1983; 336: 377
• 14 Kerry R, Scrutton MC, Wallis RB. Mammalian Platelet Adrenoceptors. Br J Pharmacol 1984; 81: 91-102
• 15 Motulsky HJ, O’Connor DT, Insel PA. Platelet alpha₂adrenergic receptors in treated and untreated essential hypertension. Clin Sci 1983; 64: 265-272
• 16 Ts’ao C-H, Green D, Schultz K. Function and ultrastructure of platelets of neonates; enhanced Ristocetin in aggregation of neonatal platelets. Br J Haematol 1976; 32: 225-233
• 17 MacFarlane DE, Stump DC. Parallel observation of the occupancy of the alpha2 adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase. Molec Pharmacol 1982; 22: 574-579
• 18 Jacobs KH, Saur W, Schulz G. Reduction of adenylate cyclase activity in lysates of human platelets by the alpha₂ adrenergic components of epinephrine. J Cycl Nucleotide Res 1976; 2: 381-392